I know the CYL story well but liquidity has been my bugbear.If...

First 4 Last

Share
Profile

Follow
Undaunted

4,656 Posts.

905

09/02/23

20:39

Post #: 66167302
Share

Originally posted by mj873: ↑

Here is a quick cut and paste from the summary of CYL announcement today re it's Victorian ground. You are all about to join a well run company that has the potential for some serious growth.

Major breakthrough in hunt for extension of
Bendigo Goldfield with consistent visible gold
across 350m strike at new Iris Zone
New high-grade zone has shown eight visible gold samples across what
appears a continuous zone of mineralisation, immediately beneath Boyd’s
Dam
Key Points
• Drilling resumed at Four Eagles Gold Project after delays from seasonal flooding
• Eight holes have reported visible gold samples
• All samples lie within what appears a continuous zone of mineralisation
• Iris Zone extends over 350 metres in strike length; remains open north and south
• Assaysreceived to date include: 5.6m @ 54.0 g/t Au, 1.0m @ 150 g/t Au, 1.3m @ 77.9g/t
Au, 5.5m @ 10.4 g/t Au and 5.4m @ 5.2g/t Au
• Iris Zone presents first clear proof of concept that Four Eagles contains the same
structural style as the 22-million-ounce Bendigo Goldfield, where high-grade
mineralised zones repeat at depth
• Importantly, Iris adds to the number of high-grade zones close to the proposed
exploration tunnel, potentially changing project economics

I hold CYL and I also hold LSR so I know a little about VAN and how it's been traveling. Personally, I'd love to see CYL take over LSR as well!

Welcome to CYL y'all!

Expand

I know the CYL story well but liquidity has been my bugbear.

If you have the time, go back through the VAN threads for some entertaining reading on its unspectacular 18 year history!

VAN Price at posting: 4.8¢ Sentiment: None Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome